This research indicates that inflammation in breast tissue, spurred by the activity of the NFKB* pathway, causes cancer. If this inflammation can be isolated from the inflammation in the rest of the body and selectively treated, it could mean that breast cancer stem cells would die and halt the progression of the cancer.
5 6 7 8
© 2004–2010 Donna Peach. All rights reserved.